Mdm2

Mouse double minute 2 homolog (MDM2) also known as E3 ubiquitin-protein ligase Mdm2 is a is_associated_with::protein that in humans is encoded by the MDM2 is_associated_with::gene. Mdm2 is an important negative regulator of the is_associated_with::p53 tumor suppressor. Mdm2 protein functions both as an E3 ubiquitin ligase that recognizes the is_associated_with::N-terminal trans-activation domain (TAD) of the is_associated_with::p53 tumor suppressor and an inhibitor of is_associated_with::p53 transcriptional activation.

Discovery and expression in tumor cells
The murine is_associated_with::double minute (mdm2) is_associated_with::oncogene, which codes for the Mdm2 protein, was originally cloned, along with two other genes (mdm1 and mdm3) from the transformed mouse cell line 3T3-DM. Mdm2 overexpression, in cooperation with oncogenic Ras, promotes transformation of primary rodent fibroblasts, and mdm2 expression led to tumor formation in is_associated_with::nude mice. The human homologue of this protein was later identified and is sometimes called Hdm2. Further supporting the role of mdm2 as an is_associated_with::oncogene, several human is_associated_with::tumor types have been shown to have increased levels of Mdm2, including soft tissue sarcomas and osteosarcomas as well as breast tumors. An additional Mdm2 family member, Mdm4 (also called MdmX), has been discovered and is also an important negative regulator of is_associated_with::p53.

Ubiquitination target: p53
The key target of Mdm2 is the is_associated_with::p53 tumor suppressor. Mdm2 has been identified as a p53 interacting protein that represses p53 transcriptional activity. Mdm2 achieves this repression by binding to and blocking the is_associated_with::N-terminal trans-activation domain of p53. Mdm2 is a p53 responsive gene—that is, its transcription can be activated by p53. Thus when p53 is stabilized, the transcription of Mdm2 is also induced, resulting in higher Mdm2 protein levels.

E3 ligase activity
Mdm2 also acts as an E3 ubiquitin ligase, targeting both itself and p53 for degradation by the is_associated_with::proteasome (see also is_associated_with::Ubiquitin). Several is_associated_with::lysine residues in p53 is_associated_with::C-terminus have been identified as the sites of ubiquitination, and it has been shown that p53 protein levels are downregulated by Mdm2 in a proteasome-dependent manner. Mdm2 is capable of auto-polyubiquitination, and in complex with p300, a cooperating E3 ubiquitin ligase, is capable of polyubiquitinating p53. In this manner, Mdm2 and p53 are the members of a negative feedback control loop that keeps the level of p53 low in the absence of p53-stabilizing signals. This loop can be interfered with by is_associated_with::kinases and genes like is_associated_with::p14arf when p53 activation signals, including is_associated_with::DNA damage, are high.

Structure and function
The full-length transcript of the mdm2 gene encodes a protein of 491 is_associated_with::amino acids with a predicted molecular weight of 56kDa. This protein contains several conserved is_associated_with::structural domains including an N-terminal p53 interaction domain, the structure of which has been solved using is_associated_with::x-ray crystallography. The Mdm2 protein also contains a central acidic domain (residues 230-300). The is_associated_with::phosphorylation of residues within this domain appears to be important for regulation of Mdm2 function. In addition, this region contains nuclear export and import signals that are essential for proper nuclear-cytoplasmic trafficking of Mdm2. Another conserved domain within the Mdm2 protein is a is_associated_with::Zinc finger domain, the function of which is poorly understood.

Mdm2 also contains a is_associated_with::C-terminal RING domain (amino acid resdiues 430-480), which contains a Cis3-His2-Cis3 consensus that coordinates two molecules of is_associated_with::zinc. These residues are required for zinc binding, which is essential for proper folding of the RING domain. The RING domain of Mdm2 confers E3 ubiquitin ligase activity and is sufficient for E3 ligase activity in Mdm2 RING autoubiquitination. The RING domain of Mdm2 is unique in that it incorporates a conserved Walker A or P-loop motif characteristic of is_associated_with::nucleotide binding proteins, as well as a nucleolar localization sequence. The RING domain also binds specifically to is_associated_with::RNA, although the function of this is poorly understood.

Regulation
There are several known mechanisms for regulation of Mdm2. One of these mechanisms is is_associated_with::phosphorylation of the Mdm2 protein. Mdm2 is phosphorylated at multiple sites in cells. Following is_associated_with::DNA damage, phosphorylation of Mdm2 leads to changes in protein function and stabilization of is_associated_with::p53. Additionally, phosphorylation at certain residues within the central acidic domain of Mdm2 may stimulate its ability to target p53 for degradation. The induction of the is_associated_with::p14arf protein, the alternate reading frame product of the is_associated_with::p16INK4a locus, is also a mechanism of negatively regulating the p53-Mdm2 interaction. is_associated_with::p14arf directly interacts with Mdm2 and leads to up-regulation of p53 transcriptional response. ARF sequesters Mdm2 in the is_associated_with::nucleolus, resulting in inhibition of nuclear export and activation of p53, since nuclear export is essential for proper p53 degradation.

Inhibitors of the MDM2-p53 interaction include the cis-imidazoline analog is_associated_with::nutlin.

Levels and stability of Mdm2 are also modulated by ubiquitylation. Mdm2 auto ubiquitylates itself, which allows for its degradation by the is_associated_with::proteasome. Mdm2 also interacts with a ubiquitin specific protease, is_associated_with::USP7, which can reverse Mdm2-ubiquitylation and prevent it from being degraded by the proteasome. It is interesting to note that is_associated_with::USP7 also protects from degradation the p53 protein, which is a major target of Mdm2. Thus Mdm2 and USP7 form an intricate circuit to finely regulate the stability and activity of p53, whose levels are critical for its function.

Interactions
Mdm2 has been shown to interact with:


 * ABL1,
 * ARRB1,
 * ARRB2,
 * is_associated_with::CCNG1,
 * is_associated_with::CTBP1,
 * is_associated_with::CTBP2,
 * DAXX,
 * DHFR,
 * is_associated_with::EP300,
 * ERICH3,
 * is_associated_with::FKBP3,
 * is_associated_with::FOXO4,
 * is_associated_with::GNL3,
 * is_associated_with::HDAC1,
 * is_associated_with::HIF1A,
 * is_associated_with::HTATIP,
 * IGF1R,
 * is_associated_with::MDM4,
 * NUMB,
 * P16,
 * is_associated_with::P53,
 * is_associated_with::P73,
 * is_associated_with::PCAF,
 * is_associated_with::PSMD10,
 * is_associated_with::PSME3,
 * RPL5,
 * is_associated_with::RPL11,
 * PML,
 * is_associated_with::RPL26,
 * is_associated_with::RRM2B,
 * is_associated_with::RYBP,
 * TBP, and
 * UBC.

Mdm2 p53-independent role
Mdm2 overexpression was shown to inhibit DNA double-strand break repair mediated through a novel, direct interaction between Mdm2 and Nbs1 and independent of p53. Regardless of p53 status, increased levels of Mdm2, but not Mdm2 lacking its Nbs1-binding domain, caused delays in DNA break repair, chromosomal abnormalities, and genome instability. These data demonstrated Mdm2-induced genome instability can be mediated through Mdm2:Nbs1 interactions and independent from its association with p53.